Introduction {#S1}
============

The human Na^+^/H^+^-exchanger (NHE; SLC9) family comprises 13 proteins: SLC9A1-SLC9A9 (NHE1-9), SLC9B1 and B2 (NHA1, NHA2), and SLC9C1 and C2 ([@B42]). Occasionally, SLC9C1 and C2 are also called NHE10 and NHE11, respectively ([@B42]). NHEs are differentially expressed in virtually all human tissues and organs that are characterized by their specific physiological functions ([@B100]; [@B159]).

NHE1, for example, has been located in the basolateral membrane of polarized epithelial cells, where it is responsible for intracellular pH homeostasis, Na^+^ uptake and the maintenance of cell volume ([@B19]). On the other hand, NHE1 was found to accumulate in the leading edge of migrating cells ([@B49]; [@B133]), particularly in invadopodia of malignant tumor cells of epithelial origin. NHE1 contributes to cell motility, both structurally as a cytoskeletal anchor and functionally by regulating pH and cell volume. Especially intra- and extracellular pH nanodomains in close proximity to the plasma membrane affect cytoskeletal dynamics, cell adhesion and the activity of MMPs ([@B142]).

The digestive system consists of the gastrointestinal tract including esophagus, stomach, small intestine and large intestine, as well as the auxiliary organs: tongue, salivary glands, pancreas, liver and gallbladder. Several NHE isoforms are involved in the pathogenesis of diseases of the digestive system such as IBD ([@B93]) or digestive system tumorigenesis ([@B71]). However, while the vast majority of review articles focuses on the role of NHE family members in IBD ([@B93]) or infectious diarrhea in gut ([@B26]), so far, only a few reviews report on the role of NHEs in digestive system tumorigenesis. Therefore, in this review, we will describe the pathophysiology of NHEs in the digestive system, including injury repair, infectious diarrhea, IBD, digestive system tumorigenesis, and others. [Table 1](#T1){ref-type="table"} and [Figure 1](#F1){ref-type="fig"} summarize the information given throughout the text and include the relevant references.

###### 

NHE isoforms, their locations, (patho)physiological impact, and relevant references.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **NHE isoforms**   **Digestive organ**   **Physiological purpose/Expression/(Mal)Function**                                                                                                         **Pathological manifestation**                                                                                                                                          **References**
  ------------------ --------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------
  NHE1               Esophagus             • To protect esophageal cells from the detrimental effects of gastric acid\                                                                                • GERD\                                                                                                                                                                 [@B132]; [@B113]\
                                           • Basolateral acidification of extracellular space and tissue damage\                                                                                      \                                                                                                                                                                       [@B132]; [@B134]\
                                           • Increased NHE1 expression/activity defends intracellular pH\                                                                                             • GERD\                                                                                                                                                                 [@B37]; [@B109]; [@B46]; [@B74]\
                                           \                                                                                                                                                          \                                                                                                                                                                       \
                                           • Na^+^-dependent Ca^2+^-extrusion\                                                                                                                        • Barrett's esophagus\                                                                                                                                                  [@B45]; [@B50]\
                                           \                                                                                                                                                          \                                                                                                                                                                       [@B9]
                                           • Proliferation, migration, invasion, and apoptosis                                                                                                        \                                                                                                                                                                       
                                                                                                                                                                                                      • Esophageal adenocarcinoma\                                                                                                                                            
                                                                                                                                                                                                      \                                                                                                                                                                       
                                                                                                                                                                                                      • ESCC                                                                                                                                                                  

  NHE1               Stomach               • Initiation of cell migration during gastric epithelial restitution\                                                                                      • Gastric epithelial repair\                                                                                                                                            [@B111]\
                                           • Not essential for mouse gastric epithelial repair\                                                                                                       \                                                                                                                                                                       \
                                           • Insulin-like growth factor II-induced proliferation and carbachol-/insulin-like growth factor II-stimulated migration in human gastric myofibroblasts\   • Gastric epithelial repair\                                                                                                                                            [@B163]\
                                           • Proliferation, migration, and invasion of gastric cancer cells                                                                                           \                                                                                                                                                                       \
                                                                                                                                                                                                      • Gastric epithelial repair\                                                                                                                                            [@B25]\
                                                                                                                                                                                                      \                                                                                                                                                                       \
                                                                                                                                                                                                      \                                                                                                                                                                       \
                                                                                                                                                                                                      \                                                                                                                                                                       \
                                                                                                                                                                                                      • Gastric cancer                                                                                                                                                        [@B89]; [@B58]; [@B104]; [@B61]; [@B156]; [@B158]

  NHE1               Intestine             • NHE1-mediated Na^+^ absorption\                                                                                                                          • Shiga toxin 1 induced diarrhea\                                                                                                                                       [@B76]\
                                           • NHE1 expression was inhibited\                                                                                                                           • Rotavirus induced diarrhea in children\                                                                                                                               [@B91]; [@B21]\
                                           \                                                                                                                                                          • UC, CD\                                                                                                                                                               [@B68]; [@B145]\
                                           • Down-regulated in colon\                                                                                                                                 \                                                                                                                                                                       [@B67]; [@B36]\
                                           \                                                                                                                                                          • UC, CD\                                                                                                                                                               [@B47]; [@B167]; [@B14]
                                           • Up-regulated in colon\                                                                                                                                   \                                                                                                                                                                       
                                           \                                                                                                                                                          • DMH-induced CRC                                                                                                                                                       
                                           • Up-regulated in colon                                                                                                                                                                                                                                                                                                            

  NHE1               Liver                 • Up-regulated\                                                                                                                                            • NAFLD\                                                                                                                                                                [@B114]\
                                           • Up-regulated\                                                                                                                                            • Hepatic ischemia injury\                                                                                                                                              [@B86]; [@B154]\
                                           \                                                                                                                                                          \                                                                                                                                                                       [@B164]; [@B165]
                                           • NHE1 correlates with tumor size, invasiveness and tumor progression                                                                                      • HCC                                                                                                                                                                   

  NHE1               Pancreas              • Locally acidic extracellular conditions favor tumor cell invasion                                                                                        • PDAC                                                                                                                                                                  [@B118]; [@B63]; [@B106]; [@B107]

  NHE2               Stomach               • Completion of cell migration during gastric epithelial restitution\                                                                                      • Gastric epithelial repair\                                                                                                                                            [@B111]\
                                           • Trefoil factor peptides in mouse gastric epithelial restitution requires NHE2 activity\                                                                  \                                                                                                                                                                       \
                                           • Parietal cell differentiation and longevity                                                                                                              • Gastric epithelial repair\                                                                                                                                            [@B163]; [@B96]\
                                                                                                                                                                                                      \                                                                                                                                                                       [@B128]; [@B13]
                                                                                                                                                                                                      • NHE2 deficiency is accompanied by a strong, but not total loss of parietal cells the murine stomach                                                                   

  NHE2               Intestine             • NHE2 activity inhibited\                                                                                                                                 • Cholera toxin induced diarrhea\                                                                                                                                       [@B144]\
                                           • Down-regulated\                                                                                                                                          • TNBS-induced colitis in rats\                                                                                                                                         [@B136]\
                                           • Mediates only butyrate- dependent Na^+^ absorption                                                                                                       • DSS-induced ulcerative colitis                                                                                                                                        [@B117]

  NHE3               Intestine             • The major Na^+^ importer                                                                                                                                 • ETEC induced diarrhea                                                                                                                                                 [@B59]

                                           • NHE3 activity and protein expression was inhibited                                                                                                       • Cholera toxin induced diarrhea                                                                                                                                        [@B144]

                                           • Sodium absorption and acid secretion in human colon                                                                                                      • *Clostridium difficile* induced antibiotic-associated diarrhea                                                                                                        [@B56]; [@B35]

                                           • Down-regulated                                                                                                                                           • IBD in patients or mice                                                                                                                                               [@B145]; [@B166]; [@B36]; [@B84], [@B85]

  NHE3               Liver                 • Decreased expression of NHE3 in cholangiocytes                                                                                                           • Cholestasis and liver fibrosis                                                                                                                                        [@B127]

  NHE3               Gallbladder           • Increased level of NHE3 phosphorylated at serine-552                                                                                                     • Cholesterol gallstone                                                                                                                                                 [@B22]

  NHE3               Pancreatic duct       • In murine pancreatic ducts CFTR controls expression and regulates activity of NHE3                                                                       • NHE3 contributes to abnormal pancreatic secretion in cystic fibrosis in mice                                                                                          [@B2]

  NHE4               Stomach               • In the basolateral membrane of parietal cells, the differentiation of gastric epithelial cells and the secretion of gastric acid                         • NHE4 deficiency in mice causes a decrease in parietal cell number, a loss of mature chief cells, and an increase in the number of mucous and undifferentiated cells   [@B43]

  NHE4               Intestine             • NHE4 activity can be reduced                                                                                                                             • *Escherichia coli* heat-stable enterotoxin induced diarrhea                                                                                                           [@B11]

  NHE6               Intestine             • NHE6 expression was inhibited                                                                                                                            • Rotavirus induced diarrhea in children                                                                                                                                [@B91]; [@B21]

  NHE8               Stomach               • In the apical membrane of the stomach's surface mucous cells, bicarbonate secretion and gastric epithelial repair                                        • NHE8 deficiency causes a decrease in gastric mucosal surface pH and an increased incidence of gastric ulcer                                                           [@B161]

  NHE8               Intestine             • Mucosa protection, mucus secretion                                                                                                                       • NHE8 deficiency causes increased inflammation/inflammatory cytokines                                                                                                  [@B162]; [@B153]

  NHE8               Intestine             • Controls Wnt/β-catenin signaling and Lgr5 expression                                                                                                     • NHE8 deficiency promotes CRC                                                                                                                                          [@B160]

  NHE9               Intestine             • Up-regulated                                                                                                                                             • CRC                                                                                                                                                                   [@B151]

  NHA2               Pancreas              • Clathrin-mediated endocytosis and insulin secretion in β-cells                                                                                           • Pathological glucose tolerance with diminished insulin secretion                                                                                                      [@B28]
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

![Schematic diagram depicting NHEs that have been known to be related to the pathogenesis of digestive diseases.](fphys-10-01566-g001){#F1}

NHEs in Esophageal Epithelial Pathology {#S2}
=======================================

The Role of NHEs in Esophageal Injury and Repair {#S2.SS1}
------------------------------------------------

Gastroesophageal reflux disease is characterized by the destruction of the esophageal mucosa caused by uncontrolled reflux of gastric acid, which eventually leads to the formation of esophageal ulcers ([@B168]). Due to the fact that NHE1 expression at mRNA level was detected in both rat and rabbit esophagus, it was assumed that NHE1 may be associated with cytoplasmic pH regulation in esophageal cells and thus contributes to the esophageal defense against the gastric acid reflux ([@B132]). To investigate a possible, protective impact of NHE1 on those esophageal cells that are exposed to an extremely acidic environment caused by gastric acid reflux, normal, primary esophageal epithelial cells were cultured and then exposed to an acidic medium of pH 4.0 for up to 12 h. Under these acidic conditions, NHE1 inhibition led to a significant decrease in cell viability suggesting that NHE1 indeed has the ability to protect esophageal cells against the detrimental effects of gastric acid ([@B113]). In this scenario, NHE1 activity is thought to be stimulated by the PKC pathway and Ca^2+^/calmodulin ([@B41]) which could be mediated by EGF released from the salivary glands ([@B97]; [@B72]). On the contrary, based on the presence of NHE1 in the basolateral membrane of the esophageal epithelium ([@B132]), Siddique and Khan ([@B134]) argue that the protons extruded by NHE1 lead to a basolateral acidification of the extracellular space which could then cause tissue damage and eventually GERD. They found that NHE1 expression was up-regulated in GERD patients in a histamine-dependent manner via H~2~ receptors. Consequently, they consider NHE1 as a potential therapeutic target and suggest to inhibit NHE1, e.g., by H~2~-receptor blockers, in order to treat GERD ([@B134]). However, as further explained in the following section, in ESCC, NHE1 has been found to act as a tumor suppressor and to be of prognostic value ([@B9]).

The Role of NHE1 in Barrett's Esophagus and Its Progression to Esophageal Tumorigenesis {#S2.SS2}
---------------------------------------------------------------------------------------

Barrett's esophagus represents a pre-malignant condition in which original, normal squamous epithelial cells of the distal esophagus have been replaced by columnar-lined intestinal cells. Over time, this so-called intestinal metaplasia tends to become esophageal adenocarcinoma ([@B16]). Although the exact pathological mechanism leading to Barrett's esophagus is unclear, it is likely to be caused by long-term chronic reflux of gastric or even bile acid and digestive enzymes. [@B46] reported that, compared to its expression in normal esophageal epithelium and normal esophageal cells, NHE1 is highly expressed not only in biopsies from patients with Barrett's esophagus, but also in the CP-A cell line derived from Barrett's esophagus. Due to the frequent acid exposure of esophageal cells over a long period, the progressive intestinal metaplasia occurring in Barrett's esophagus may represent an adaptive process ([@B109]), which is accompanied by an increase in NHE1 expression in order to defend intracellular pH.

Both bile acids and extracellular acidification, particularly in combination, stimulate the activity of the cytosolic nitric oxide synthase (NOS) and thus nitric oxide (NO) production ([@B46]). NO can inhibit NHEs ([@B24]), which leads to a substantial cytosolic acidification causing DNA damage and subsequent tumor progression ([@B46]). On the other hand, [@B74] found that upon chronic exposure to bile acids, NHE1 expression was up-regulated in the Barrett's esophageal cell lines CP-A and CP-D, at both mRNA and protein level. Besides, it was found that NHE1 activity but not NHE1 expression was increased by acid pulse stimulation in *ex vivo* Barrett's esophagus tissue, and that the elevated NHE1 activity may be responsible for the hyperproliferation of Barrett's esophagus epithelial cells, probably mediated by PKC ([@B37]). So far, neither the elicitor nor the mechanistic reasons for the differential expression of NHE1 between healthy esophageal epithelium/cells and Barrett's esophagus epithelial cells are fully understood, and further research focusing on this topic is required.

Esophageal adenocarcinoma (EAC) and ESCC are two main subtypes of esophageal cancer. While sharing a poor 5-year overall survival rate of about 15%, EAC and ESCC originate from different cells and also differ regarding their incidence and epidemiology ([@B148]). EAC is an aggressive malignancy whose occurrence can be significantly abetted by gastric or even bile acid reflux due to GERD ([@B137]).

[@B50] found that NHE1 was highly expressed in EAC tissue but not in normal esophageal epithelium. Inhibiting the expression of NHE1 with shRNA or its activity with amiloride resulted in an intracellular acidification of esophageal cancer cells which decreased their viability and even induced apoptosis. The suppression of tumor xenograft formation in nude mice could also be observed ([@B50]). Interestingly, Goldman and colleagues reported that stimulation of JH-EsoAd1 EAC cells or cells of the Barrett's esophagus cell line CP-A with hydrophobic bile acid will activate NHE. This leads to an increase in the cytosolic Na^+^ concentration which drives K^+^-efflux and decreases the driving force for Na^+^-dependent Ca^2+^-extrusion, resulting in an increased cytosolic Ca^2+^-concentration accompanied by apoptosis ([@B45]). There were, in fact, no obvious changes in intracellular pH implying that the ionic imbalance, particularly the increase in the cytosolic Ca^2+^ concentration, was more important than intracellular acidification in inducing apoptosis. Nevertheless, further studies should clarify the role of Na^+^ and H^+^ in the apoptosis of EAC.

Contrary to any expectations, in ESCC cell lines, NHE1 gene knockdown was found to promote proliferation, migration, and invasion, and to inhibit apoptosis via the activation of PI3K-AKT signaling pathway ([@B9]). In fact, NHE1 expression was significantly higher in well-differentiated ESCC tumors compared to that in poorly differentiated ESCC tumors and correlated strongly with the 5-year survival rate being much better in the group with high NHE1 expression. Therefore and surprisingly, given the multitude of publications and cancer types in which NHE1 expression/activity positively correlates with malignancy, NHE1 could be of prognostic value in ESCC.

NHEs and Gastric Epithelial Pathology {#S3}
=====================================

NHEs and Gastric Epithelial Repair {#S3.SS1}
----------------------------------

The integrity of the gastric epithelium is essential for the protection against gastric luminal contents such as gastric acid (pH 1-2), pepsin and bacteria. Gastric mucosal injury, when including the epithelium, will initiate the migration of cells located close to the wound area. Different NHE isoforms have been shown to be involved in both maintaining the integrity of the gastric epithelium and gastric epithelial cell migration. In rabbit gastric epithelium NHE1, 2, and 4 are expressed. NHE1 and NHE2 are the predominant isoforms in mucous cells where they regulate intracellular pH, especially during high gastric acidity, and NHE4 expression is higher in parietal and chief cells where it contributes to volume regulation during gastric acid secretion ([@B125]). [@B111] reported that the migration of rat gastric surface cells (RGM1) is promoted by NHE1 activation, however, inhibited by activation of NHE2. Therefore, the authors supposed that NHE1 may be responsible for the initiation while NHE2 contributes to the completion of cell migration during gastric epithelial restitution. However, based on a series of studies on NHE2 knockout mice, the team of Marshall Montrose reported that NHE2, but not NHE1, is essential for mouse gastric epithelial repair, and that the enhancing effect of trefoil factor peptides in mouse gastric epithelial restitution requires NHE2 activity ([@B163]; [@B96]). Furthermore, NHE2 may be involved in cell differentiation and longevity because its deficiency is accompanied by a strong, but not total loss of parietal cells in the murine stomach ([@B128]; [@B13]). Thus, NHE2 can be considered essential for the formation and maintenance of the normal gastric epithelium ([@B3]). Interestingly, NHE1-3 expression was detected also in human gastric myofibroblasts. In these cells, NHE1 is necessary for insulin-like growth factor II-induced proliferation and involved in carbachol- and insulin-like growth factor II-stimulated migration ([@B25]). NHE4 is located in the basolateral membrane of parietal cells. Its gene deficiency in mice causes (i) a decrease in the number of parietal cells, (ii) a loss of mature chief cells, and (iii) an increase in the number of mucous and undifferentiated cells ([@B43]). So, similar to NHE2, also NHE4 is involved in the differentiation of gastric epithelial cells and the secretion of gastric acid. NHE8 is found in the apical membrane of the stomach's surface mucous cells. In mice, NHE8 gene deficiency has no effect on the secretion of basal gastric acid ([@B161]). However, NHE8 deficiency causes a decrease in gastric mucosal surface pH and an increased incidence of gastric ulcer. In addition, the expression of the Cl^--^/HCO~3~^--^ exchanger DRA (downregulated-in-adenoma) is suppressed in NHE8 knockout mice ([@B161]). These above-mentioned observations imply that NHE8 is associated with bicarbonate secretion and gastric epithelial repair.

NHEs and Gastric Cancer {#S3.SS2}
-----------------------

Due to the important role of NHE family members, especially NHE1, in tumorigenesis and tumor progression ([@B143]; [@B142]), the role of NHEs in the pathophysiology of gastric cancer has been examined. NHE1 expression is significantly higher in both human gastric cancer tissue and cells when compared to that in normal gastric tissue and cells, and the inhibition of NHE1 suppresses proliferation, migration, and invasion of gastric cancer cells ([@B158]). In order to clarify the detailed mechanism by which NHE1 affects the pathophysiology of gastric cancer, various gastric cancer cell models were used. [@B61] found that, when human gastric cancer cells (MKN28) are stimulated with the NHE-inhibitor EIPA, the intracellular pH does not change because of a compensatory increase in HCO~3~^--^-uptake mediated by the Na^+^-driven Cl^--^/HCO~3~^--^ exchanger NDCBE ([@B61]). The concomitant decrease in the cytosolic Cl^--^ concentration is thought to activate MAPK and enhance p21 expression, which then leads to G~0~/G~1~ arrest and reduced proliferation in MKN gastric cancer cells ([@B61]). In human gastric carcinoma cells (SGC-7901), knocking down NHE1 causes a decrease in cell proliferation, G1/G0 phase arrest, increased apoptosis, and, when SCG-7901 cells are injected subcutaneously into nude mice, a reduced tumorigenic capacity ([@B89]). Moreover, in human gastric cancer cells of the MKN45 and the MKN74 line, inhibition of NHE1 activity by 2-amino-3*H*-phenoxazin-3-one (questiomycin A), a derivative of the oxidative phenoxazine, leads to a decrease in pH~i~ and promotes apoptosis ([@B104]). Altogether, inhibition of NHE1 causes changes in the ionic composition of the cytosol that are likely to contribute to the pathogenesis of gastric cancer in terms of cell proliferation, cell apoptosis, and cell cycle. In fact, NHE1 may act as a link between ion channels and tumorigenic signaling because it can be regulated through the NF-κB signaling pathway depending on both the expression and also the activity of the voltage-gated sodium channel Na~v~1.7. Na~v~1.7 is found to be abundantly expressed in both gastric cancer tissue and the gastric cell lines BGC-823 and MKN-28 ([@B156]).

It has been known that overexpression of VEGF is critical for tumor formation and vascularization. In human gastric cancer cells (SGC7901), a decrease in pH~i~ induced by NHE1 inhibition is accompanied by an increase in VEGF expression at both mRNA and protein level ([@B58]). This illustrates the role of NHE1 in the pathophysiology of gastric cancer once more. There may be even more mechanisms to be elucidated by which NHE1 and the triggering or progress of gastric cancerogenesis could be interwoven.

NHEs and Intestinal Disease {#S4}
===========================

The Function of NHE in Intestinal Inflammation and Diarrheal Disease {#S4.SS1}
--------------------------------------------------------------------

Intestinal Na^+^ absorption is mastered mainly by NHEs so that NHE inhibition will result in the reduction of Na^+^ absorption accompanied by osmotic or even secretory diarrhea ([@B52]). Enterotoxigenic *Escherichia coli* (ETEC) are one of the most common pathogens known to cause intestinal diarrhea ([@B51]; [@B95]). When intestinal epithelial cells of the Caco-2 line are stimulated with EPEC, the total activity of all NHEs in their entirety is increased. This impact on NHE activity requires the type III secretion system (TTSS), a complex multiprotein structure produced by some gram-negative bacteria that enables them to inject their prokaryotic molecules into the eukaryotic host cell. Interestingly, EPEC infection leads to a significant increase in the basolateral NHE1 activity, a ∼300% increase in apical NHE2 and a 50% decrease in apical NHE3 activity ([@B59]). The massive decrease in the activity of NHE3 as the major Na^+^ importer, probably combined with an EPEC-mediated decrease in apical Cl^--^/HCO~3~^--^ exchange, is thought to contribute, at least in part, to the pathophysiological basis of EPEC-induced diarrhea ([@B59]).

Shiga toxin 1 from enterohemorrhagic *Escherichia coli* causes a depletion of galectin-3 which leads to mistargeting of apical proteins in T84 cells. In addition to villin and dipeptidyl peptidase IV, also NHE2, one of the major colonic Na^+^ absorptive proteins, is mistargeted into basolateral compartments. Consequently, the resulting failure of NHE2-mediated Na^+^ absorption will contribute to diarrhea ([@B76]).

Also in T84 cells, the activity of NHE4 can be reduced by *Escherichia coli* heat-stable enterotoxin via up-regulation of cAMP and PKA activity. [@B11] speculate that the subsequent intracellular acidification may induce an increase in the conductance of the apically located CFTR accompanied by an increased Cl^--^ efflux into the intestinal lumen and, thus, promotes the pathogenesis of diarrhea.

The opening probability of the Cl^--^ conducting CFTR is strongly increased by cholera toxin. Basically, the cholera toxin causes the adenylyl cyclase to be permanently highly active, and the continuously high cAMP level stimulates Cl^--^ efflux through CFTR, thus breeding and feeding secretory diarrhea ([@B62]). In addition to this tremendous increase in Cl^--^ secretion the cholera toxin causes a considerable decrease in the apical Na^+^ resorption. In rat ileum treated with cholera toxin *in vivo*, the total NHE activity was reduced by 70%. NHE2 activity, but not its expression, was inhibited while both activity and protein expression of NHE3 were inhibited by the cholera toxin ([@B144]).

*Clostridium difficile* is primarily responsible for antibiotic-associated diarrhea coming along with reductions in NHE3 expression, Na^+^ absorption and acid secretion in human colon ([@B35]). In kidney epithelial and placental cell lines, the group of John Orlowski and Sergio Grinstein observed a retranslocation of the apically located NHE3 to subapical endomembrane compartments in response to the *Clostridium difficile* toxin B ([@B56]). They propose that clostridial toxin B induces a change in the ezrin-mediated interaction between NHE3 and the microvillar cytoskeleton via inactivation of Rho-family GTPases ([@B56]).

Rotavirus is the leading etiology of acute watery diarrhea in children and one of common causes of death in children under the age of 5 years ([@B108]; [@B150]). Although the rotavirus inhibits the expression of the basolaterally located NHE1 and the organellar NHE6 in Caco-2 cells ([@B21]), it is mainly the rotavirus nonstructural protein NSP4 that causes diarrhea by inhibiting SGLT (Na^+^, glucose-cotransporter)-mediated Na^+^- and glucose-absorption and by increasing both the paracellular permeability and the phospholipase/IP3-controlled cytosolic Ca^2+^ concentration (\[Ca^2+^\]~i~). An increase in \[Ca^2+^\]~i~ then stimulates luminal Cl^--^ secretion ([@B91]).

Intestinal NHEs in IBD {#S4.SS2}
----------------------

Inflammatory bowel disease is a chronic inflammatory disorder which is classified into UC and CD ([@B10]). One of the common symptoms in IBD patients is diarrhea, possibly caused by NHEs' dysfunction ([@B93]). Compared to healthy probands, NHE1 expression in colonic biopsies from both UC and CD patients is reduced at mRNA and protein level ([@B68]). Also, Sullivan et al. reported that NHE1 is down-regulated in the colon from patients who suffer from UC or CD, and in the colon from DSS- and TNBS-induced IBD mouse models ([@B145]). In contrast, [@B67] found that NHE1 expression at mRNA and protein level is significantly increased in acetic acid- and TNBS-induced colitis in Sprague-Dawley rats. Furthermore, [@B36] reported that the activity of NHE1 including its mRNA expression are significantly upregulated in the colonic crypts isolated from UC patients compared to those from healthy human. These contradictions are probably due to pathophysiological differences between IBD animal models and among patients ([@B68]).

NHE2 is located mainly in the apical membrane of colonic epithelial cells. Its deficiency does not lead to intestinal diarrhea in mice ([@B129]; [@B82]). In colon biopsies from IBD patients, NHE2 expression and activity are not significantly changed ([@B145]; [@B36]). Given the multitude of proinflammatory cytokines secreted under the pathological condition of IBD, both TNF-α (tumor necrosis factor α) and IFNγ (interferon γ) could suppress NHE2 expression and activity in the intestinal epithelial cells through NF-κB activation ([@B123]; [@B6]). Furthermore, [@B136] reported that in colon from Sprague-Dawley rats with TNBS-induced colitis NHE2 expression is down-regulated at both mRNA and protein level, which implies that NHE2 is indeed involved in the pathogenesis and pathophysiology of IBD. Surprisingly, [@B117] found that neither NHE2 nor NHE3 are altered in the inflamed colon obtained from Sprague-Dawley rats with DSS-induced UC compared to the normal colon from untreated specimens. In addition, NHE3 conducts both HCO~3~^--^-dependent and butyrate-dependent Na^+^ absorption under normal physiological conditions, while NHE2 is activated by DSS-induced UC and mediates only butyrate-dependent Na^+^ absorption in the inflamed colon ([@B117]). Since NHE2 is active mainly under pathophysiological conditions, targeting the mechanism of butyrate activation of NHE2 could be a novel therapeutic strategy to treat diarrhea in IBD.

NHE3 is primarily located in the surface area of colonic crypts and its functional deficiency contributes significantly to the diarrheal syndrome in IBD ([@B80]). [@B145] reported that NHE3 protein expression is down-regulated in mucosal biopsies taken from the sigmoid colon of IBD patients as well as in the colon from mice with DSS- and TNBS-induced colitis. Furthermore, it was revealed that in the intestinal epithelial cells of the C2BBe1 line both IFNγ and TNF-α can inhibit NHE3 expression via PKA-mediated phosphorylation of the transcription factors Sp1 and Sp3 ([@B123]; [@B5]). Based on these observations, the decrease in NHE3 protein expression could be considered a possible reason for IBD-associated diarrhea. On the other hand, however, [@B36] found in colonic crypts isolated from UC patients and healthy controls that, while NHE3 activity was indeed inhibited in the colon from UC patients compared to that from healthy controls, NHE3 mRNA expression remained unchanged. Similarly, [@B166] reported that although neither NHE3 expression nor its localization in the brush border membrane was changed in sigmoid colon from UC patients, NHE3 activity including Na^+^ absorption were reduced significantly. Also in colons of IL-10 (interleukin 10) deficient mice and in mice with DSS-induced colitis NHE3 activity is down-regulated whereas its expression and membrane localization are not affected. In search of the mechanism by which NHE3 activity is reduced [@B84] found that both mRNA and protein expression of PDZK1, a scaffold protein forming a submembranous signal complex together with NHE3, are down-regulated which may be the possible reason for the dysfunction of NHE3 in IBD. Furthermore, DSS-induced colitis in mice is accompanied by high expression of pro-inflammatory cytokines such as interleukin IL-1β and TNF-α, the loss of NHE3 and PDZK1, and a decreased fluid absorption in colon. The pathological conditions mentioned above could be counteracted by a concomitant anti-TNF-α treatment resulting in both the restoration of the NHE3 and PDZK1 location in the apical region of enterocytes and the normalization of NHE3-mediated fluid absorption ([@B85]). This finding further confirms the role of PDZK1 in NHE3 (dys)function and subsequent diarrhea in IBD.

The Impact of NHEs on Gut Microbiota and Intestinal Mucosal Integrity {#S4.SS3}
---------------------------------------------------------------------

The homeostasis of gut microbiota is essential for the integrity of the intestinal mucosa and the maintenance of the intestinal microenvironment. An alteration of the gut microbiota can lead to various intestinal diseases, such as IBD ([@B105]), *Clostridium difficile* infection ([@B27]), irritable bowel disease ([@B138]), and others. NHE-mediated alterations in the intestinal microenvironment, such as changes in luminal ion concentration and pH, could damage the gut microbiota. For instance, gram-positive bacteria such as *Clostridium* and *Lactobacillus* are increased in cecum and colon of NHE2 knockout mice although the total luminal and mucosa-associated bacteria remain unchanged ([@B34]). Also NHE3 knockout has an impact on the murine gut microbial environment, which includes a decrease in *Lachnospiraceae* and *Ruminococcaceae* (Firmicutes) and an increase in *Bacteroidaceae*. These changes in the microbiome then lead to the initiation and intensification of colitis. Hence, disruption of NHE3 function in gut may modulate the pathogenesis and progression of colitis via alteration of the microbial ecology ([@B54]). In addition, NHE3 deficiency reinforces the T-cell mediated immune response to a disturbed gut microbiome ([@B81]). Consequently, NHE3 plays an important role in keeping the gut's microbial ecology balanced, and NHE3 malfunction caused by inflammatory cytokines results in the onset and fuels the progress of the IBD. Furthermore, in NHE3-deficient mice, the luminal ion composition and pH are altered locally leading to region-specific changes in the composition of the bacterial population ([@B33]). Compared to NHE3 wild-type mice, the diversity of the luminal and mucosal microbiota in NHE3 knockout mice is significantly decreased ([@B79]), and the bacterial composition in their intestine affects the severity of colitis ([@B79]). In summary, NHE3 is essential for the generation and maintenance of an intact microbiota, because NHE3 deficiency is accompanied by the pathogenesis of IBD, probably caused by a disproportion in the bacterial composition.

NHE8 contributes significantly to intestinal mucosa protection. In NHE8 knockout mice the expression of mucin 2, an important component of the mucus layer, is clearly decreased ([@B162]). The mucus layer coats the intestinal epithelium and represents a defense mechanism against both commensal and pathogenic bacteria by separating the apical membranes of intestinal epithelial cells from the luminal contents. In DSS-treated NHE8 knockout mice, the low mucin production in goblet cells and a reduced production of enteric defensins, due to decreases in both the number of mature goblet cells and the population of functional Paneth cells, indicate that NHE8 contributes to the intestinal mucosal integrity through goblet and Paneth cells. According to this, the DSS-treated NHE8 knockout mice are characterized by increased inflammation and elevated expressions of IL-1β, IL-6, IL-4, and TNF-α ([@B153]).

In their entirety, the above-mentioned findings suggest that NHEs have a strong impact on the gut microbiota and the integrity of the intestinal mucosa, and that NHE dysfunction can be associated with the pathogenesis of various intestinal diseases.

NHE and Colon Cancer {#S5}
====================

Intracellular acidification is a trigger in the early phase of apoptosis and results in activation of endonucleases inducing DNA fragmentation, whereas alkalinization of the cytosol is an early event in malignant transformation and plays an essential role in tumor progression ([@B64]). In solid tumors, cellular pH regulators, particularly NHE1, are up-regulated, and the resulting intracellular alkalinization and extracellular acidification play crucial roles in cell proliferation, invasion and metastasis ([@B121]). Accordingly, NHE1-deficient cells show no or a strongly reduced tumor growth *in vivo* ([@B126]). Furthermore, cells lacking NHE activity exhibit a markedly impaired proliferation, indicating that NHE activity is important for tumor growth and cell proliferation ([@B64]). A recent study by Stine Pedersen's lab demonstrates how both the intracellular steady state pH and NHE1 expression vary over the different phases of the cell cycle ([@B38]). The authors propose that cell cycle phase-specific regulation of the intracellular pH~i~ is controlled by NHE1 and the Na^+^, HCO~3~^--^ -cotransporter NBCn1. On the whole, NHE1, the activity of which is triggered by cellular acidosis and cell shrinkage, has an anti-apoptotic effect ([@B78]). This is consistent with the observation that activating the Fas receptor - which can induce apoptosis - inhibits NHE1 activity in T-lymphocytes via activation of the Src-like kinase Lck^56^ ([@B77]). Conversely, mitogen- or growth factor-induced phosphorylation of specific regions of NHE1's regulatory C-terminus is essential for NHE1 activity and can counter both cell shrinkage and intracellular acidification. NHE1 interacts with proteins of the ezrin, radixin, moesin (ERM) family ([@B29]) and also with CD44 ([@B14]), an adhesion molecule which (i) is also known to interact with ERM proteins, (ii) is ubiquitously expressed in cancer cells and (iii) regulates cell adhesion and motility ([@B47]; [@B167]). Even the formation of tumor cell pseudopodia is regulated by NHE1, on the one hand via its interaction with F-actin-associated proteins, on the other hand by local pH regulation ([@B94]; [@B92]).

To date, there are only a few studies reporting on the involvement of NHEs in colon cancer. Vaish and Sanyal found in rats that the protein expression level of NHE1 is significantly higher in DMH-induced CRC tissue than in colorectal tissue of the control group. Co-administration of DMH and non-steroidal anti-inflammatory drugs (NSAIDs) such as the CRC-preventing sulindac and celecoxib leads to significant decreases in NHE1 expression implying that NHE1 contributes to colonic tumor progression ([@B152]). Both the activity and the expression of NHE1 are increased also in doxorubicin-resistant (HT29-dx) human colon carcinoma cells suggesting a role for NHE1 in the development of multidrug resistance in tumor cells ([@B101]). NHE1-mediated alkalinization of the cytosol seems to facilitate Wnt/β-catenin signaling in human colorectal tumor cells ([@B131]). Constitutive Wnt/β-catenin signaling is accompanied by redistribution of β-catenin into the nucleus and a decreasing expression of E-cadherin. In epithelial cells, low or even no *E*-cadherin expression is an indicator for malignant transformation. [@B131] discuss Akt-activity as the possible mechanistic link between NHE1-modulated cytosolic pH and Wnt/β-catenin signaling.

An increased Wnt/β-catenin signaling is found also in the absence of NHE8 ([@B160]). The absence of NHE8 most likely makes a considerable contribution to the development of intestinal tumors, because it is expressed in normal human colon tissue, but cannot be detected in CRC. Furthermore, in the azoxymethane/dextran sodium sulfate cancer model, only 9% of NHE wild-type mice displayed tumorigenesis as opposed to 89% in NHE8 knockout mice. Finally, NHE8 deficiency is accompanied by an elevated expression of the stem cell marker Lgr5 in the colon ([@B160]).

Recently, the physiological function of NHE9 has been widely investigated in various human cell lines and tissues. [@B151] revealed by immunohistochemical analysis that NHE9 is up-regulated in CRC compared to normal tissue. NHE9 is closely related to EGFR (EGF receptor) signaling pathways. Its overexpression promotes the progression and the metastatic potential of CRC and, thus, may be a prognostic marker and a potential therapeutic target ([@B151]).

Role of NHEs in Hepatic Ischemia and Liver Cancer {#S6}
=================================================

Increased Na^+^ influx via ion transporters including Na^+^/H^+^ exchangers is required for hepatocyte proliferation ([@B70]). As reported by Forgac and Arias, an amiloride-sensitive Na^+^/H^+^ exchanger is situated in the sinusoidal domain of the plasma membrane of rat hepatocytes and probably involved in the regulation of pH~i~ ([@B8]). In primary cultures of hepatocytes treated with EGF, the increase in pH~i~ is indeed mediated by the Na^+^/H^+^ exchanger whose activation is tyrosine kinase-dependent and regulated by modulations of the cytosolic Ca^2+^ concentration including Ca^2+^-calmodulin-dependent pathways ([@B149]). NHE activity is significantly higher in basolateral plasma membrane vesicles isolated from neonatal rat liver than in those from adults. This is due to an increased number or an increased individual activity of antiporters in the neonatal plasma membrane ([@B48]).

Hepatic stellate cells, also known as perisinusoidal cells, represent the major cell type involved in liver fibrosis. Quiescent stellate cells constitute 5-8% of the total number of liver cells. HSCs can become activated when the liver is damaged. An activated HSC is characterized by proliferation, contractility, and chemotaxis. In this state, HSCs are the main source of extracellular matrix production in the context of liver injuries and also responsible for secreting collagen into the scar tissue which, eventually, can result in cirrhosis. Na^+^/H^+^ exchange is the main regulator responsible for pH~i~ homeostasis in rat HSCs. Activation of HSCs is associated with an increased NHE activity accompanied by an elevated steady state pH~i~, and it also contributes to proliferation in response to stimulation by the platelet derived growth factor (PDGF) ([@B30]). Activation of NHE in HSCs occurs also in oxidative stress-associated liver fibrosis, implying that the Na^+^/H^+^ exchange might act as a common mediator of diverse effects induced by oxidative stress. Moreover, the NHE inhibitor amiloride can suppress HSC proliferation and collagen secretion which suggests NHE to be a potential therapeutic target in the treatment of liver fibrosis ([@B146]). Similarly, *in vivo* findings showed that liver fibrosis induced by dimethylnitrosamine or bile duct ligation can be significantly ameliorated by simultaneous administration of amiloride ([@B55]).

Development of fibrosis is crucial in the pathogenesis of NAFLD ([@B124]; [@B147]), and NHE activity might also be involved in NAFLD induced by HFD. Compared to WT mice with a normal chow diet, livers of mice with HFD displayed a nearly twofold increase in NHE1 expression, suggesting a potential role of NHE activity in different stages of NAFLD ([@B114]). Long-term ablation of NHE1 activity in mice attenuates HFD-induced lipid accumulation in liver and preserves insulin sensitivity ([@B114]). Strong inhibition of NHE1, present not only in the plasma membrane but also in the mitochondrial inner membrane, may as well have protective effects in chronic liver diseases leading to steatosis and fibrosis because it is accompanied by a decrease in ROS production, i.e., an indirect increase in antioxidant potential, and an improved mitochondrial efficiency in energy conversion ([@B65]; [@B4]). Furthermore, like in myocardial ischemia, NHE1-inhibition by EIPA reduces oxidative liver damage caused by reperfusion after ischemia in a rat model ([@B154]). Ischemic conditions impede the end-oxidation in the mitochondria which leads to an accumulation of H^+^ ions. This decline in cytosolic pH stimulates NHE1 activity resulting in an increased cytosolic Na^+^ concentration accompanied by a decrease in the driving force for the Na^+^/Ca^2+^ exchanger. The consequential elevation of the cytosolic Ca^2+^ concentration modulates or inhibits enzyme activities and even induces apoptosis ([@B86]).

In rat hepatocytes, agents promoting liver tumors, such as α-hexachlorocyclohexane or phenobarbital, cause an intracellular alkalinization mediated by Na^+^/H^+^ antiport. A higher cytosolic pH then stimulates DNA synthesis which is an important event in malignant transformation and tumor progression ([@B83]). In HCC tissues, increased NHE1 expression levels correlate with tumor size, the ability of invasiveness and tumor progression ([@B165]). *In vitro*, inhibition of NHE1 expression via siRNA-mediated knockdown reduces HCC growth and induces apoptosis. Moreover, treatment with EIPA suppresses tumor growth in nude mouse xenografts of HCC cells ([@B164]), suggesting that NHE1 might be a potential therapeutic target in HCC.

Cholangiocytes represent the cuboidal epithelium in the small interlobular bile ducts and contribute to bile secretion via net release of HCO~3~^--^ and H~2~O. NHE3 is expressed in the luminal membranes of murine and rat cholangiocytes where it plays a role in fluid secretion and absorption from the luminal space ([@B99]). Cultured cholangiocytes isolated from patients with primary biliary cirrhosis exhibit impaired functions of the Cl^--^/HCO~3~^--^ anion exchanger 2 (AE2) and amiloride-sensitive NHE(s). Moreover, the insensitivity of AE2 and NHE to secretory stimuli results in the inability of the biliary epithelium to alkalinize and hydrate the bile, which consequently aggravates the cholestatic condition and at the same time may be a molecular mechanism underlying, at least contributing to, the impaired HCO~3~^--^ secretion during cholestatic disease ([@B98]). Bile duct ligation as an experimental model to induce cholestasis and liver fibrosis in rats results in decreased expression of NHE3 in cholangiocytes, which, due to lower Na^+^-(re-)absorption, may contribute to the enhanced salt and fluid secretion of rat livers in response to stimulation with secretin ([@B127]). Altogether, the above-mentioned observations strongly support the view that reduced NHE3 activity is responsible for a diminished absorptive capacity in cholangiocytes.

Physiology and Function of NHEs in Gallbladder {#S7}
==============================================

Since in the gallbladder, absorption of water and electrolytes is (i) associated with luminal proton secretion and (ii) inhibitable by amiloride ([@B155]; [@B120]), NHEs are believed to play an important role in this process. Early studies demonstrate that in the human gallbladder NHE3 is expressed only in the absorptive epithelial cells and is therefore likely to be the major isoform involved in water and electrolyte absorption from bile ([@B135]). In prairie dogs, however, both of the apical isoforms NHE2 and NHE3, but not NHE1, contribute to Na^+^ uptake and transepithelial Na^+^ absorption ([@B1]). A rather recent study shows an increased level of NHE3 phosphorylated at serine-552 in response to diet-induced cholesterol gallstone formation in mice. This increase in phosphorylation is thought to lead to a higher turnover of NHE3 resulting in a downturn of the gallbladder's concentrating function. The other way around, decreased bile absorption by the gallbladder may be the result of decreased exchanger activity due to phosphorylation-induced turnover in murine gallbladder epithelium cells ([@B22]). Further studies are required to address the underlying mechanisms.

NHEs in Pancreas {#S8}
================

The pancreas is a mixed glandular organ both in the digestive and the endocrine system of vertebrates. It functions as an important endocrine organ by producing several hormones including insulin, glucagon, somatostatin, and pancreatic polypeptide, all of which circulate in the blood. As a digestive organ, the pancreas secretes (i) pancreatic juice containing HCO~3~^--^ to neutralize the acidic chyme arriving from the stomach and (ii) digestive enzymes that facilitate digestion and absorption of nutrients in the small intestine.

In murine islets of the endocrine pancreas eight NHE isoforms are expressed at mRNA level. Among these, two, namely NHE1 and NHE5, are located predominantly in the plasmalemma and six are found intracellularly, including NHA1, NHA2, NHE6, 7, 8, and 9. NHA1 and NHA2 belong to the SLC9B subgroup (SLC9B1 and SLC9B2, respectively) and are also known as NHEDC1 and NHEDC2. To date, just the ubiquitous isoform NHE1 and the recently cloned isoform NHA2 have been fully investigated in β-cells ([@B102]; [@B28]).

Secretion of insulin by pancreatic β-cells is highly relevant to circulating glucose levels. Glucose uptake into β-cells is mediated by the SLC2 (GLUT) transporter family and leads to the initiation of the insulin secretion cascade ([@B103]). High glucose increases the cytoplasmic pH of primary β-cells and β-cell lines ([@B88]; [@B32]). In the 1980s, glucose-induced intracellular alkalinization was believed to be the key event in insulin secretion ([@B88]). Later, [@B66] reasoned that the glucose-induced alkalinization was a result of plasmalemmal NHE activity because it depended on extracellular Na^+^ and was sensitive to the NHE inhibitor EIPA. However, contrary studies showed that insulin secretion was stimulated by NHE inhibition but hindered by intracellular alkalinization ([@B110]; [@B12]). In order to address this inconsistency, [@B140] investigated NHE1 mutant mice (NHE1^swe/swe^, swe, slow wave epilepsy). They concluded that NHE1 is the only NHE isoform present in the cell membrane of murine β-cells and activated at low intracellular pH in the absence of HCO~3~^--^/CO~2~. Under physiological conditions, however, the intracellular alkalinization caused by high glucose is entirely dependent on HCO~3~^--^ production ([@B140]). Moreover, NHE1 has no impact on stimulus-secretion coupling, and the NHE inhibitors EIPA and DMA, but not the selective NHE1 inhibitor cariporide, stimulate insulin secretion without pH~i~ changes in both NHE1 wild-type and mutant islets ([@B140]). There is a Na^+^ background current in pancreatic β-cells the nature of which has not been further characterized ([@B40]). It might well be that EIPA and DMA affect this Na^+^ background current and thus contribute to a depolarization of the membrane potential which is essential for the Ca^2+^-dependent release of insulin.

The role of NHA2 in insulin secretion has been less controversial. The NHA2 protein resides in transferrin-positive endosomes and synaptic-like microvesicles (SLMVs), but not in insulin-containing, large and dense core vesicles (LDCVs) ([@B28]). In *in vivo* studies on two different NHA2 knock-out strains, mice were subjected to intraperitoneal glucose and insulin tolerance tests. The experiments revealed a pathological glucose tolerance with diminished insulin secretion, but at the same time a normal peripheral insulin sensitivity. *In vitro* studies on islets isolated from NHA2 knock-out or heterozygous mice demonstrate a deficient insulin secretion after stimulation with glucose or the antihyperglycemic agent tolbutamide ([@B28]). The data from [@B28] indicate a pivotal role of NHA2 in both clathrin-mediated endocytosis and insulin secretion in β-cells, suggesting that defective endo-exocytosis coupling may be the mechanism underlying the secretory deficit observed in NHA2-deficient mice. The precise function of NHA2 still remains unclear and future work should address the potential involvement of NHA2 in the pathogenesis of β-cell disorders in humans.

The exocrine part of the pancreas represents up to 90% of the pancreatic mass and is composed of acinar, centroacinar, and ductal cells. The secretory cells of the acini surround small intercalated ducts and contain plenty of small, visible granules of zymogens ([@B112]). In response to extracellular stimuli, pancreatic acinar cells synthesize, package, and secrete zymogens. They also secrete an isotonic, NaCl-rich, neutral fluid. Ductal cells exchange Cl^--^ for HCO~3~^--^ in order to produce an alkaline fluid, thus providing an optimal pH for digestive enzymes and neutralizing the gastric acid entering the duodenum ([@B139]; [@B60]). Several NHE isoforms have been detected in the pancreas, although their cellular or organellar distribution and functions have not been fully investigated. NHE1 is ubiquitously expressed and localized to the basolateral membrane of pancreatic ductal epithelial cells ([@B7]). It has been observed that Nhe1^--/--^ murine acinar cells fail to recover from an acid load, suggesting that NHE1 is the major isoform responsible for Na^+^/H^+^ exchange ([@B15]). Additionally, even in the presence of extracellular HCO~3~^--^, acini from Nhe1^--/--^ animals do not recover from an intracellular acid challenge, implying that basolateral Na^+^/HCO~3~^--^ exchange was unable to compensate for the loss of NHE1 to buffer the pH~i~ changes ([@B15]). In contrast, NHE2 and NHE3 seem to play a minor role in the pancreatic acinar cells since acini isolated from either Nhe2^--/--^ or Nhe3^--/--^ mice showed no difference in the pH~i~ recovery from an acid load when compared to WT mice ([@B7]). Nonetheless, NHE3 expression and activity in the luminal membranes of mouse pancreatic ducts are measurably affected by CFTR ([@B2]). On the other hand, NHE3 expression could not be confirmed in the human pancreatic ductal carcinoma cell line CFPAC1 ([@B119]). NHE4 is found to be located in the basolateral membranes of pancreatic acinar and duct cells. NHE1 and NHE4 are also present in membranes of zymogen granula of rat exocrine pancreas ([@B7]).

To date, there have been limited reports in respect of the function of NHE in pancreatic diseases. A recent study revealed that the NHE1 inhibitor EIPA inhibits micropinocytosis in PDAC, and micropinocytosis is required for albumin-dependent cancer cell proliferation ([@B23]). This observation is consistent with a series of previous findings of the importance of NHE1 activity for endocytotic processes ([@B63]). Moreover, other studies also showed expression and function of NHE1 in several PDAC cell lines ([@B118]). It has been found that NHE1 activation by growth factors like neurotensin and its analogs was accompanied by phosphorylation of serine residues of the exchanger, leading to locally acidic extracellular conditions favoring tumor cell invasion at a very early stage of tumor development ([@B106]; [@B107]). At the same time, NHE1 favors formation of invadopodial structures ([@B18]) required for invasion which is consistent with the general idea that an acidic extracellular pH promotes tumor invasion by stimulation of protease secretion and induction of proinvasive mediators, and also by suppression of apoptosis through intracellular alkalinization ([@B75]; [@B17]).

Targeted Therapy {#S9}
================

Modulation of NHE1 Expression/Activity as a Potential Therapeutic Target in Digestive System Malignancy {#S9.SS1}
-------------------------------------------------------------------------------------------------------

In recent years an increasing number of publications have emphasized the growing importance of hydrogen ion dynamics in modern cancer research, from etiopathogenesis to treatment. Among all NHE family members, NHE1 is the best studied and has been demonstrated to be directly associated with cellular transformation, proliferation, invasion and metastasis ([@B90]). As described earlier in this review, NHE1 plays important roles in the tumorigenesis of various digestive organs such as HCC, ESCC, gastric cancer, colon cancer and PDAC. An elevated NHE1 activity, resulting in both an increase in intracellular pH and a decrease in the extracellular pH of tumors, is considered to be the major factor in promoting extracellular/interstitial acidity already at the earliest pre-cancer stage of oncogene-driven neoplastic transformation ([@B53]). Inhibition of NHE1 expression or activity leads to tumor cell growth arrest, acidification of the intracellular space, apoptosis and inhibition of glycolysis ([@B122]; [@B20]). These observations have boosted the interest in NHE1 as a promising and highly selective drug target in anticancer therapy ([@B141]). For instance, amiloride, the first NHE inhibitor, was shown to lower VEGF production and to reduce the activity of MMPs, urokinase-type plasminogen activator (μPA), and other proteases, all of which facilitate the initiation and progression of the metastatic process ([@B69]; [@B57]; [@B115]; [@B116]). Another study showed that suppression of (i) NHE1 expression by using siRNA or (ii) NHE1 activity by using EIPA reduces proliferation/growth and induces apoptosis of HCC cells. EIPA also inhibits tumor growth in nude mouse xenografts of HCC cells, suggesting that inhibition of NHE1 could be a potential therapeutic target for the treatment of HCC ([@B165]). [@B31] have also demonstrated that cariporide, a non-amiloride derivative, and other selective and potent inhibitors of NHE1 reduce proliferation and induce apoptosis in cholangiocarcinoma cells. Furthermore, in human PDAC cell lines, NHE1 drives both basal and EGF-stimulated three-dimensional growth and early invasion via invadopodial extracellular matrix digestion. Cariporide was found to reduce growth and invasion independently of the PDAC subtype and to sensitize these cells to low doses of erlotinib ([@B18]), supporting the potential therapeutic value of cariporide.

Targeting NHE3 Activity as a Treatment Modulator for Diarrhea and Irritable Bowel Syndrome {#S9.SS2}
------------------------------------------------------------------------------------------

Secretory diarrhea usually results from abnormal fluid and electrolyte absorption and/or secretion. Electroneutral fluid absorption is carried out by the coordinated activity of NHE3 with Cl^--^/HCO~3~^--^ exchangers ([@B130]; [@B157]). Studying cell cultures and rodent models revealed that NHE3 is inhibited in secretory diarrhea, and that NHE3 activity in enterocytes is inhibited under the conditions of acutely elevated intracellular concentrations of Ca^2+^, cAMP, or cGMP, caused by bacterial enterotoxins, humoral agonists or ionophores ([@B87]; [@B44]). Enteroids generated from human proximal small intestine show an NHE3 activity which is stimulated by dexamethasone and inhibited upon exposure to rotavirus, cholera toxin and bacterial enterotoxins ([@B39]). A peptide that mimics part of the NHE3 C-terminal domain prevents NHE3 inhibition by cAMP, Ca^2+^ and cholera toxin, suggesting the potential utility of NHE3 as a therapeutic target in such conditions.

Another study showed the use of tenapanor and its analogs in patients with constipation-predominant irritable bowel syndrome and for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis, implying that NHE3 inhibitors could be regarded as potential stool softeners in constipation-predominant irritable bowel syndrome. But both the safety and the long-term efficiency of NHE3 inhibition still remain unclear and need further study ([@B73]; [@B169]).

Conclusion and Perspective {#S10}
==========================

There is a multitude of studies dealing with the physiology and pathophysiology of NHEs in the gastrointestinal tract. While it is indisputable that NHE1-3 and NHE8 play prominent roles in most if not even all segments of the gastrointestinal tract, the functions and the significance of NHE4, and NHA2 are rather inconclusive, so that further studies are needed indeed. Furthermore, observations made in, and the results obtained from, the various model systems such as cell culture, organoid, mouse and rat are hard to compare and cannot be directly applied to human beings. This specifically applies to the complex interaction between microbiota and intestinal epithelia, including the role of short chain fatty acids, which has gained more and more interest over the last two decades. There are studies showing that short chain fatty acids have an impact on the expression of NHE isoforms ([@B144]). Here the differences between the models are even more momentous because (i) cells in culture and organoids need to be mixed with short chain fatty acids and (ii) different species prefer different food leading to species-dependent differences in the composition of both microbiota and their short chain fatty acids. This flaw needs to be overcome in order to give more importance to the individual study with its results/observations. A first step could be a well-defined global standardization of the model systems and a systematic characterization of their differences and similarities based on which the findings and their impact could be assessed and classified.
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CD

:   Crohn's disease

CRC

:   colorectal cancer

DMA

:   dimethylamiloride

DMH

:   1,2-dimethylhydrazine dihydrochloride

DSS

:   dextran sulfate sodium

EGF

:   epidermal growth factor

EIPA

:   5-(*N*-ethyl-*N*-isopropyl)-amiloride

EPEC

:   enteropathogenic *Escherichia coli;*

ESCC

:   esophageal squamous cell carcinoma

GERD

:   gastroesophageal reflux disease

HCC

:   hepatocellular carcinoma

HFD

:   high-fat-diet

HSC

:   hepatic stellate cells

IBD

:   inflammatory bowel disease

IFN γ

:   interferon γ

IL-1 β

:   interleukin 1 β

IL-4

:   interleukin 4

IL-6

:   interleukin 6

MMPs

:   matrix metalloproteinases

NAFLD

:   non-alcoholic fatty liver disease

NF-κB

:   nuclear factor "kappa-light-chain-enhancer" of activated B-cells

PDAC

:   pancreatic ductal adenocarcinoma

PDZK1

:   human gene encoding the Na^+^/H^+^ exchange regulatory co-factor NHE-RF3

PKA

:   protein kinase A

PKC

:   protein kinase C

TNBS

:   2,4,6-trinitrobenzenesulfonic acid

TNF- α

:   tumor necrosis factor α

UC

:   ulcerative colitis

VEGF

:   vascular endothelial growth factor.
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